The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Exelixis Inc

Nasdaq: EXEL
Last

(U.S.) $5.60

Today's change-0.35 -5.88%
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Exelixis Inc

Nasdaq: EXEL
Last

(U.S.) $5.60

Today's change-0.35 -5.88%
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.

Exelixis Inc crosses below 20-day moving average

Exelixis Inc closed sharply lower Tuesday, dropping (U.S.)$0.35 or 5.88% to (U.S.)$5.60 and crossing below its 20-day moving average. Over the last five days, shares have gained 7.28% and 288.89% year to date. Shares have outperformed the S&P 500 by 39.73% during the last year.

Key company metrics

  • Open(U.S.) $5.75
  • Previous close(U.S.) $5.95
  • High(U.S.) $5.85
  • Low(U.S.) $5.47
  • Bid / Ask(U.S.) $5.60 / (U.S.) $5.62
  • YTD % change+288.89%
  • Volume10,045,183
  • Average volume (10-day)7,362,244
  • Average volume (1-month)6,674,609
  • Average volume (3-month)6,492,864
  • 52-week range(U.S.) $1.26 to (U.S.) $6.81
  • Beta2.70
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.02
Updated September 1 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX2.72%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue8976
Total other revenue--------
Total revenue8976
Gross profit7976
Total cost of revenue1111
Total operating expense39325458
Selling / general / administrative13101010
Research & development25224044
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1034
Other operating expenses, total--------
Operating income-31-23-46-52
Interest income (expense), net non-operating-12-12-12-12
Gain (loss) on sale of assets--------
Other--------
Income before tax-43-35-58-63
Income after tax-43-35-58-63
Income tax, total----0--
Net income-43-35-58-63
Total adjustments to net income--------
Net income before extra. items-43-35-58-63
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-43-35-58-63
Inc. avail. to common incl. extra. items-43-35-58-63
Diluted net income-43-35-58-63
Dilution adjustment--------
Diluted weighted average shares196196196195
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.18-0.30-0.32
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.21-0.18-0.28-0.30